text1 stringlengths 2 245 | text2 stringlengths 3 1.79k | value float64 0.3 0.5 | category stringclasses 145
values |
|---|---|---|---|
(-)-5-(3',4'-dihydroxyphenyl)-valerolactone | metabolite of catechins | 0.3 | D |
(-)-5-m-hydroxyphenyl-2-methylmorphan | analgesic agonist-antagonist; rn refers to (-)-isomer; ; do not confuse with phenylmorphan | 0.3 | D |
(-)-6a,7-dehydrofloripavidine | isolated from papaver | 0.3 | D |
(-)-7-N-methyldibromophakellin | phakellin alkaloid from an agelas sp. sponge, collected near wewak, papua new guinea | 0.3 | D |
(-)-7-N-methylmonobromophakellin | phakellin alkaloid from an agelas sp. sponge, collected near wewak, papua new guinea | 0.3 | D |
(-)-7beta-hydroxy-8alpha-methoxydeepoxysarcophytoxide | from the vietnamese soft coral sarcophyton mililatensis | 0.3 | D |
(-)-8-hydroxy-3-(4-hydroxypentyl)-3,4-dihydroisocoumarin | from talaromyces verruculosus | 0.3 | D |
(-)-alpha-methoxy-alpha-(trifluoromethyl)phenylacetyl chloride | acylating agent used to determine enantiomeric purity of amines & alcohols; rn given refers to (-)-isomer | 0.3 | D |
(-)-alpha-pinene synthase | catalyzes the conversion of geranyl diphosphate to pinene and diphosphate | 0.3 | D |
(-)-cermizine B | lycopodium alkaloid | 0.3 | D |
(-)-maalioxide | sesquiterpenoid isolated from the liverwort, plagiochila acanthophylla subsp. japonica | 0.3 | D |
(0.017ferrocene)amylose | a redox polymer consisting of 1 ferrocene residue per 60 glucose units; partial | 0.3 | D |
(1 R,11 alpha)-1,4-epoxy-11-hydroxy-3,4-secolupane-20(30)-ene-3,28-dioic acid | from acanthopanax sessiliflorus fruits | 0.3 | D |
(1 R,11 alpha,22 alpha)-1,4-epoxy-11,22-hydroxy-3,4-secolupane-20(30)-ene-3,28-dioic acid | from acanthopanax sessiliflorus fruits | 0.3 | D |
(1''-pyrene butyl)-2-rhodamine ester | an oxygen dependence probe in mitochondria of living cells | 0.3 | D |
(1''R)-5,4',1''-trihydroxy-6,7-(3'',3''-dimethylchroman)flavone | flavone with antihyperglycemic activity from eysenhardtia platycarpa | 0.3 | D |
(1'-(4-fluorophenyl)(ethylenedioxy))-21-hydroxy-19-norpregn-4-ene-3,20-dione | a potential imaging agent for receptor-positive breast tumors; ; rn refers to the 16ar-isomer | 0.3 | D |
(1'-(4-fluorophenyl)(ethylenedioxy))pregn-4-ene-3,20-dione | ; rn refers to (16ar)-isomer | 0.3 | D |
(1'R,5R,6R)-3-(4-amino-1,1-dimethyl-butyl)-6-(1'-hydroxyethyl)oxapenem-3-carboxylate | oxapenem compound which possesses potent beta-lactamase-inhibitory properties | 0.3 | D |
(1'S, 2S)-4-amino-N-(1'-carbamoyl-2'-phenylethyl)-2-(4''-methyl-1''-naphthalenesulfonylamino)butanamide | a somatostatin receptor 4 agonist | 0.3 | D |
(1'S,2'R)-8-(2,3-epoxy-1-hydroxy-3-methylbutyl)-7-methoxycoumarin | from the dried fructus of cnidium monnieri | 0.3 | D |
(1,1'- bi-2-naphthyl)-23-crown-6 incorporating 1,4-benzoquinone | redox-active crown ether | 0.3 | D |
(1,1'- bi-2-naphthyl)-23-crown-6 incorporating 9,10-anthraquinone | redox-active crown ether | 0.3 | D |
(1,1'-biphenyl)-3-yl (2-(5-hydroxy-1H-indol-3-yl)ethyl)carbamate | a fatty acid amide hydrolase (faah) inhibitor | 0.3 | D |
(1,1-cyclobutanedicarboxylato)(2,2'-bipyridine)palladium(II) | covalently modifies dna | 0.3 | D |
(1,1-cyclobutanedicarboxylato)(2,2'-bipyridine)platinum(II) | covalently modifies dna | 0.3 | D |
(1,1-dimethylethoxy)carbonyl-glycyl-delta-phenylalanyl-leucyl-delta-phenylalanyl-N-methylalaninamide | ; used for studying helical formation of peptides; contains two alpha, beta-dehydrophenylalanine residues | 0.3 | D |
(1,1-dimethylethoxy)carbonyl-tyrosyl-prolyl-glycyl-phenylalanyl-leucyl-threonine | a delta opioid receptor antagonist; amino acid sequence given in first source | 0.3 | D |
(1,1-dioxido--3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl 4-(((phenylmethoxy)carbonyl)amino)benzoate | tryptase inhibitor | 0.3 | D |
(1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl 5-(((phenylmethoxy)carbonyl)amino)pentanoate | tryptase inhibitor | 0.3 | D |
(1,10-phenanthroline)(9,10-phenanthrenequinonediimine)rhodamine(III) | cross-links rna | 0.3 | D |
(1,2,3,9-tetrahydro-3-((5-methyl-1H-imidazol-4-yl)methyl)-9-(3-amino-(N-fluorescien-thiocarbamoyl)-propyl)-4H-carbazol-4-one) | high-affinity antagonist for serotonin 5-ht3 receptor | 0.3 | D |
(1,2,4)triazolo(1,5-a)pyrimidin-7-one | non-toxic (also known as ws-10) that modulates abcb1-mediated multidrug resistance (mdr) | 0.3 | D |
(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid | a gaba-c receptor antagonist | 0.3 | D |
(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane | has antineoplastic activity | 0.3 | D |
(1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum (II) | rn given refers to (sp-4-2) | 0.3 | D |
(1,2-bis(2-hydroxyphenyl)ethylenediamine)dichloroplatinum (II) | rn refers to ((r-(r*,r*))-isomer | 0.3 | D |
(1,2-bis(4-fluorophenyl)ethylenediamine)dichloroplatinum(II) | ; rn given is for (sp-4-2)-(r*,r*) isomer | 0.3 | D |
(1,2-bis(6-methoxy-2H-chromen-3-yl)methylene)hydrazine | increases both tgf-1beta induction and reactive species production | 0.3 | D |
(1,2-di(cyclopentadienyl)-1,2-di(3-dimethoxyphenyl)ethanediyl)titanium dichloride | a titanocene with antineoplastic activity | 0.3 | D |
(1,2-di(cyclopentadienyl)-1,2-di(4-N,N-dimethylaminophenyl)ethanediyl)titanium dichloride | a titanocene with antineoplastic activity | 0.3 | D |
(1,2-diaminiocyclohexane)tetrakis(propionato)platinum(IV) | has antineoplastic activity | 0.3 | D |
(1,2-diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)platinum(II) | has antineoplastic activity | 0.3 | D |
(1,2-trans)-N3-(4-acetamidobutyl)-1-(3,4-dihydroxyphenyl)-7-hydroxy-N2-(4-hydroxyphenethyl)-6,8-dimethoxy-1,2-dihydronaphthalene-2,3-dicarboxamide | from the root bark of lycium chinense | 0.3 | D |
(1,3,5-triaminocyclohexane)copper(II) | promotes hydrolysis of peptides | 0.3 | D |
(1,3,7,9-tetramethylxanthine-8-ylidene)silver acetate | has antimicrobial activity | 0.3 | D |
(1,4,7)triazecan-9-ol | forms nickel(ii) and copper(ii) complexes that may serve as potential antineoplastic agents | 0.3 | D |
(1,4,7,10-tetrakis((N-(1H-imidazol-2-yl)carbamoyl)methyl)-1,4,7,10-tetraazacyclododecane)thulium(III) | a paracest contrast agent | 0.3 | D |
(1,4,7-triazacyclodecane)platinum(II) | has antineoplastic activity | 0.3 | D |
(1,4-bis(3-pyridyl)-2,3-diazo-1,3-butadiene)dichlorozinc(II) polymer | can adopt at least two different conformations | 0.3 | D |
(1,4-bis(3-pyridyl)-2,3-diazo-1,3-butadiene)dichlorozinc(II) polymer | can adopt at least two different conformations | 0.3 | D|J |
(1,5,9,13-tetrathiacyclohexadecane-3,11-diol)iridium(III) astatide | reagent for labeling biomolecules with astatine | 0.3 | D |
(1,5,9,13-tetrathiacyclohexadecane-3,11-diol)rhodium(III) astatide | reagent for labeling biomolecules with astatine | 0.3 | D |
(1,5-anhydro-7-amino-2,7-dideoxyheptopyranosyl)carboxylate | inhibitor of cmp-kdo synthetase | 0.3 | D |
(1,5-cyclooctadiene)bis((2,5-dimethylphospholano)ethane)rhodium(I) | an asymmetic hydrogenation catalyst | 0.3 | D |
(1,5-dihydroxy-2-oxopyrrolidin-3-yl)phosphonic acid | an enolase inhibitor | 0.3 | D |
(1,8-dimethyl-1,3,6,8,10,13-hexaazacyclotetradecane)nickel(II) | enhances degradation of malachite green by potassium persulfate | 0.3 | D |
(1-(((1-(1-oxo-2-N-((phenylmethoxy)carbonyl)-3-phenylpropyl)pyrrolidin-2-yl)carbonyl)amino)-4-methoxybutyl)-1-boronic acid | a thrombin inhibitor | 0.3 | D |
(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | a cannabinergic agent | 0.3 | D |
(1-((2-aminopyridin-4-yl)methyl)piperidin-4-yl)(4-((methoxyimino)(pyridin-2-yl)methyl)piperidin-1-yl)methanone | a histamine h3 receptor antagonist | 0.3 | D |
(1-((pyren-1-yl)propoxy)-3,5-bis(bis(2-pyridylmethyl)aminomethyl)benzene)zinc(II) | a fluorescent chemosensor for alarmone; binds two ions of zinc; structure in firs t source | 0.3 | D |
(1-(1-((2,4-dioxoimidazolidin-1-ylimino)methyl)-2-phenylethylcarbamoyl)-2-(1H-indol-3-yl)ethylcarbamoyl)-2-(1H-indole) | a proteasome inhibitor with antineoplastic activity | 0.3 | D |
(1-(2'-methylpropoxy)-2-hydroxy-2-methylpropoxy)butane | a metabolite from the marine bacterium vibrio angustum s14 | 0.3 | D |
(1-(2-(5-(N,N-dimethylamino)naphthalenesulfonamido)ethyl)-1,4,7,10-tetraazacyclododecane)zinc(II) | putative apoptosis detector | 0.3 | D |
(1-(2-fluoroethyl)piperidin-4-yl)methyl 8-amino-7-chloro-2,3-dihydrobenzo(b)(1,4)dioxine-5-carboxylate | a radiotracer for serotonin 4 receptors | 0.3 | D |
(1-(3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1,3-thiazol-2-yl)amino)-6-methoxyquinazolin-7-yl)oxy)propyl)piperidin-4-yl)methyl dihydrogen phosphate | prodrug of an aurora a and aurora b kinase inhibitor | 0.3 | D |
(1-(3-aminophenyl)-1H-pyrrol-3-yl)(3,4,5-trimethoxyphenyl)methanone | a tubulin polymerization inhibitor with antineoplastic activity | 0.3 | D |
(1-(3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(4-(methylamino)phenyl)methanone | a ligand of the vesicular acetylcholine transporter | 0.3 | D |
(1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)methyl methanesulfonate | a gpr119 agonist | 0.3 | D |
(1-(4-((4-methoxybenzyl)amino)quinazolin-2-yl)piperidin-2-yl)methanol | a pancreatic beta-cell protective agent | 0.3 | D |
(1-(4-(2-(hexahydropyrrolo(3,4-c)pyrrol-2(1H)-yl)-1H-benzimidazol-1-yl)piperidin-1-yl)cyclooctyl)methanol | a nociceptin/orphanin fq receptor agonist | 0.3 | D |
(1-(4-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)methyl 6-methyl-2-oxo-4-(4-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate | has antitubercular activity | 0.3 | D |
(1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl)-methanol | an antineoplastic agent | 0.3 | D |
(1-(4-chlorobenzyl)-N-(2-methoxybenzyl)-1H-pyrazole-3-carboxamide | has anti-hiv activity | 0.3 | D |
(1-(4-dimethylaminobenzyl)piperidin-4-yl)-4((3,3-dimethylbutyl)phenyl)-(3-methylbut-2-enyl)amine | an n-type calcium channel blocker | 0.3 | D |
(1-(4-fluorophenyl)-4a-methyl-5,6,7,8-tetrahydro-4H-benzo(f)indazol-5-yl)-(4-(trifluoromethyl)phenyl)methanol | a glucocorticoid receptor modulator | 0.3 | D |
(1-(4-hydropentyl)indol-3-yl)-(1-naphthyl)methanone | a metabolite of jwh-018 | 0.3 | D |
(1-(4-hydroxy-3-isopropyl-benzyl)-3-methyl-1H-indol-5-yloxy)acetic acid | a thyroid hormone receptor beta agonist | 0.3 | D |
(1-(4-toluenesulfonyl)cytosine)zinc(II) | has antineoplastic activity; structure of ligand in first source | 0.3 | D |
(1-(5-chloro-4-oxo-4H-3,1-benzoxazin-2-yl)-2-methylpropyl)carbamic acid 1,1-dimethylethyl ester | pancreatic elastase inhibitor | 0.3 | D |
(1-(5-dimethylaminonaphthalene)sulfonamido)-n-hexanoic acid-beta-N-trimethylammonium ethyl ester | rn given refers to bromide | 0.3 | D |
(1-(5-hydropentyl)indol-3-yl)-(1-naphthyl)methanone | a metabolite of jwh-018 | 0.3 | D |
(1-(7-imino-3-propyl-2,3-dihydrothiazolo(4,5-d)pyrimidin-6(7H)-yl)urea | antiparkinson agent | 0.3 | D |
(1-(7-methoxy-2,2-dimethyl-2H-chromen-6-yl)ethyl)-2-methylbutenoate | an antiprotozoal agent; isolated from ageratum conyzoides | 0.3 | D |
(1-(8-(2-fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(4-fluorophenyl)methanone | a pet radiotracer for imaging the vesicular acetylcholine transporter | 0.3 | D |
(1-(N'-(4-hydroxy-4-(2-hydroxyindan-1-ylcarbamoyl)-5-phenylpentyl)-N'-(4-pyridin-4-ylbenzyl)hydrazinocarbonyl)-2,2-dimethylpropyl)carbamic acid methyl ester | an hiv-1 protease inhibitor | 0.3 | D |
(1-(aminomethyl)-3-methylcyclohexyl)acetic acid | binds to alpha2delta subunit of a calcium channel; gabapentine analog | 0.3 | D |
(1-(chloromethyl)-1,2-dihydropyrrolo(3,2-e)indol-3(6H)-yl)(5-fluoro-1H-indol-2-yl)methanone | rendered into a cytotoxic compounds by cyp2w1 | 0.3 | D |
(1-(hydroxymethyl)-4-(4-methyl-3-(methylethyl)pentylidene)-3-oxo-2-oxolanyl)methyl 4-methyl-3-(methylethyl)pentanoate | binds protein kinase c | 0.3 | D |
(1-3)-beta-D-glucan phosphate | beta-glucans phosphorylated for solubilization; glucan phosphate is also available | 0.3 | D |
(1-3)glucopentaose peracetate | ; rn refers to anomeric alpha-d-glucose | 0.3 | D |
(1-4)-2-amino-2-deoxy-beta-glucopyranuronan | product from oxidation & deacetylation of chitin; rn given refers to (d)-isomer | 0.3 | D |
(1-4)-2-deoxy-2-sulfoamino-beta-D-glucopyranuronan | product from oxidation & deacetylation of chitin | 0.3 | D |
(1-6)-alpha-glucomannan | rn given refers to (d)-isomer; bulk forming agent consisting of vegetable matter. isolated from amorphophallus konjac | 0.3 | D |
(1-6)-mannopyranan sulfate | strongly inhibits hiv-induced cytopathic effects | 0.3 | D |
(1-8-NαC)-zanriorb A1 | proapoptotic orbitide from leaves of zanthoxylum riedelianum | 0.3 | D |
(1-O-octadecyl-2-O-(2'-deoxy-2'-aminoglucopyranosyl)glycerol(3))phosphorylcholine | has antineoplastic activity; activates cell-matrix adhesion and migration | 0.3 | D |
(1-O-octadecyl-2-O-(2'-deoxy-2'-dimethylmaleimidoglucopyranosyl)glycerol(3))phosphorylcholine | has antineoplastic activity; activates cell-matrix adhesion and migration | 0.3 | D |
(1-amino-2-propenyl)phosphonic acid | inhibitor of alanine racemase & d-alanylalanine synthetase | 0.3 | D |
(1-aminoethyl)(2-carboxy-1-octyl)phosphinic acid | inhibits d-alanine-d-alanine ligase of e coli | 0.3 | D |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.